Plasma levels of thrombomodulin in pulmonary hypertension. 1996

P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
Department of Internal Medicine, Hopital La Pitié-Salpétrière, Paris, France.

BACKGROUND Long-standing pulmonary hypertension (PH) leads to structural alterations of the pulmonary vasculature and its endothelium, and occlusion of small vessels by microthrombi. In patients with PH, the search for factors inducing or worsening endothelium damage and in situ thrombi is still ongoing. Thrombomodulin (TM), an endothelial cell membrane protein, is a receptor for thrombin and a major anticoagulant proteoglycan. OBJECTIVE To analyze plasma TM levels in patients with different forms of severe PH. METHODS We prospectively studied 32 consecutive patients with PH referred for heart, lung, or heart-lung transplantation: 11 patients with primary PH (group 1), 11 patients with secondary precapillary PH (Eisenmenger's syndrome, group 2) and 10 patients with secondary postcapillary PH due to congestive heart failure (group 3). Thirty-eight healthy subjects were also studied as a control group. METHODS Plasma concentrations of TM were measured by an immunoenzymatic technique that uses two anti-TM monoclonal antibodies that have a strong avidity and react with different epitopes of the molecule. RESULTS Thrombomodulin plasma levels decreased in all patients with precapillary PH, and this decrease was highly significant compared with controls (26 +/- 2 versus 44 +/- 2 ng/mL, P = 0.0001). In primary PH, the TM decrease was only significant in males whereas in the Eisenmenger's syndrome TM values were the lowest of all the patients studied, with mean values twice as low as controls (22 +/- 2 versus 44 +/- 2 ng/mL, P = 0.0001). In contrast, in postcapillary PH, studied only in males, TM levels were increased (85 +/- 17 versus 54 +/- 3 ng/mL, P = 0.02). Patients with precapillary PH had more severe disease than patients with postcapillary PH, with higher pulmonary artery pressure and pulmonary vascular resistance (P < 0.001). There was no correlation between TM plasma levels and all hemodynamic variables. CONCLUSIONS We found low levels of plasma TM in patients with precapillary PH but not in postcapillary PH compared with healthy controls. This may be related to the severity of PH and may contribute to the initiation or worsening of in situ thromboses frequently found in pulmonary hypertension. Further studies should analyze whether other markers of endothelial cell damage are correlated with plasma TM levels in patients with precapillary pulmonary hypertension.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018180 Thrombomodulin A cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation.

Related Publications

P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
March 1991, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
January 1993, Gynecologic and obstetric investigation,
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
December 1995, Obstetrics and gynecology,
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
February 2003, Clinical and experimental hypertension (New York, N.Y. : 1993),
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
October 1997, The American journal of medicine,
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
May 2013, The Tohoku journal of experimental medicine,
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
June 1999, Panminerva medica,
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
April 2009, Journal of thrombosis and thrombolysis,
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
February 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
P Cacoub, and M Karmochkine, and R Dorent, and P Nataf, and J C Piette, and P Godeau, and I Gandjbakhch, and M C Boffa
January 1998, The Turkish journal of pediatrics,
Copied contents to your clipboard!